Bill Malcolm
- A UK based cost-utility analysis of indacaterol - A once-daily maintenance bronchodilator for patients with COPDBy Yumi Asukai, Jaithri Ananthapavan, Bill Malcolm, Amr Radwan and Ian KeyzorYumi Asukai1Health Economics and Outcomes Research, IMS Health, London, United KingdomJaithri Ananthapavan1Health Economics and Outcomes Research, IMS Health, London, United KingdomBill Malcolm2Scientific Operations, Novartis Pharmaceuticals UK Limited, Surrey, United KingdomAmr Radwan3Clinical Development & Medical Affairs, Novartis Pharmaceuticals UK Limited, Surrey, United KingdomIan Keyzor4Health Economics and Outcomes Research, Novartis Pharmaceuticals UK Limited, Surrey, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.